• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Top Trading Strategy
No Result
View All Result
Home Breaking News

Pfizer delays its FDA application to expand its Covid vaccine to kids under 5 until April

by
February 11, 2022
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Virgin Orbit scrambles to avoid bankruptcy as deal talks continue

JPMorgan Chase can be sued by Virgin Islands over Jeffrey Epstein sex-trafficking claims

Pro Picks: Watch all of Monday’s big stock calls on CNBC

Republicans request Fed and FDIC oversight records for failed Silicon Valley Bank and Signature Bank

Brayden Burton, 3, plays with child life specialist Maggie Kail, CCLS while being treated for coronavirus disease (COVID-19) at the Children’s Hospital of Georgia in Augusta, Georgia, U.S., January 14, 2022.
Hannah Beier | Reuters

Pfizer and BioNTech on Friday said they were delaying their request for the Food and Drug Administration to authorize the vaccine for children under 5 until at least April, as they wait for data on the efficacy of a third dose.

“Cases continue to accumulate according to the study protocol and more data are being generated because rates of infection and illness remain high in children of this age, especially due to the recent Omicron surge,” Pfizer said in a statement.

The FDA said it’s postponing a meeting Tuesday that was scheduled to look at the kids’ data.

The Centers for Disease Control and Prevention was already laying the groundwork to distribute the shots, telling state and local health officials they could receive their first shipments by Feb. 21.

The CDC plans to roll out 10 million doses in three phases as soon as the Food and Drug Administration authorizes the lower-dose, 3-microgram Pfizer and BioNTech shot for children 6 months to 4 years old, according to a new planning document quietly issued Sunday. State and local health officials could start preordering the first doses Monday and will start receiving vaccine shipments on Presidents Day, according to the CDC.

Pfizer and BioNTech asked the FDA last week to expand the authorization for their vaccine to most kids under 5. The FDA had asked the companies to start submitting data for authorization of the first two-doses of the three-dose vaccine for children six months through 4-years-old.

Pfizer and BioNTech expect kids under 5 will ultimately need three doses for the highest level of protection against the omicron Covid variant and future strains of the virus. The companies said data on the third dose will be finished and submitted to the FDA in the coming months.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:

No one knows when the pandemic will end after omicron upended most hope of returning to normal

Here’s what experts say about Covid vaccines for kids under age 5

New York state lifts indoor mask mandate as surge in omicron cases subsides

CDC tells health officials to expect first shipments of young kids’ Covid shots by Feb. 21

Covid fatigue is making the pandemic worse — and prolonging its end, experts say

WHO says omicron BA.2 subvariant will rise globally, but it’s unclear if it can reinfect people

Pfizer CEO says chances are ‘very high’ FDA will approve low-dose Covid shots for kids under 5

Johnson & Johnson plant pauses Covid vaccine production, report says

Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill

Pfizer amended its clinical trial for younger kids in December to study a third shot after the first two doses did not produce an adequate immune response in children 2- to 4-years-old. Younger kids will receive a smaller, three microgram dose compared with the 30 microgram shots that are approved for adults.

Children under 5-years-old are the last age group left in the U.S. that isn’t eligible for vaccination. There has been growing public pressure from many parents and doctors for the FDA to speed up authorization of the vaccine as the omicron variant has lead to an increase in children hospitalized with Covid.

Pfizer and BioNTech said last week that their application for emergency approval came in response to an “urgent public health need” for younger children as omicron has caused an unprecedented wave of infection across the country.

Next Post

Jeffrey Gundlach says preserving capital is key. Here are the sectors he likes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

Virgin Orbit scrambles to avoid bankruptcy as deal talks continue

by
March 20, 2023
0

In this article VORB Follow your favorite stocksCREATE FREE ACCOUNT Virgin Orbit's LauncherOne rocket on display in Times Square, New...

Read more

Virgin Orbit scrambles to avoid bankruptcy as deal talks continue

JPMorgan Chase can be sued by Virgin Islands over Jeffrey Epstein sex-trafficking claims

Pro Picks: Watch all of Monday’s big stock calls on CNBC

Republicans request Fed and FDIC oversight records for failed Silicon Valley Bank and Signature Bank

Bitcoin soars to nine-month high as investors weigh bank risks and interest rates: CNBC Crypto World

The $17 billion wipeout of Credit Suisse bondholders has not gone down well in Europe

Load More

All rights reserved by www.toptradingstrategy.net

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.